Psyence Faces Delisting Risk If It Can't Regain Nasdaq Compliance Within 180 Days
-
Psyence Biomedical received notices from Nasdaq regarding deficiencies in market value requirements for continued listing.
-
Psyence has 180 days, until September 9th, to regain compliance with the $50M minimum market value and $15M minimum publicly held shares value.
-
Psyence stock continues to trade on Nasdaq during the 180 day compliance period.
-
If Psyence cannot demonstrate compliance by September 9th, its securities could face delisting.
-
Psyence is actively monitoring the situation and evaluating options to try to regain compliance with Nasdaq standards.